127 related articles for article (PubMed ID: 1978435)
1. Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma.
Lai FM; Cheng PN; Tsao SY; Lai KN
Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):347-52. PubMed ID: 1978435
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-DR antigens in nasopharyngeal carcinoma: an immunohistological analysis of the tumour cells and infiltrating lymphocytes.
Thomas JA; Iliescu V; Crawford DH; Ellouz R; Cammoun M; de-Thé G
Int J Cancer; 1984 Jun; 33(6):813-9. PubMed ID: 6329970
[TBL] [Abstract][Full Text] [Related]
3. Tumour infiltrating lymphocytes in nasopharyngeal carcinoma.
Chong PY; Chew CT; Chan KC; Ow CK
Ann Acad Med Singap; 1988 Apr; 17(2):238-42. PubMed ID: 3261567
[TBL] [Abstract][Full Text] [Related]
4. Increased production of interferon-gamma by tumour infiltrating T lymphocytes in nasopharyngeal carcinoma: indicative of an activated status.
Tang KF; Chan SH; Loh KS; Chong SM; Wang D; Yeoh KH; Hu H
Cancer Lett; 1999 Jun; 140(1-2):93-8. PubMed ID: 10403546
[TBL] [Abstract][Full Text] [Related]
5. Tumor infiltrating lymphocytes in HLA+ and HLA- laryngeal cancer--quantitative approach.
Dworacki G; Kruk-Zagajewska A; Jezewska E; Sikora J; Zeromski J
Arch Immunol Ther Exp (Warsz); 1999; 47(3):161-8. PubMed ID: 10470443
[TBL] [Abstract][Full Text] [Related]
6. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.
Håkansson L; Adell G; Boeryd B; Sjögren F; Sjödahl R
Br J Cancer; 1997; 75(3):374-80. PubMed ID: 9020482
[TBL] [Abstract][Full Text] [Related]
8. HLA expression in basal cell carcinomas.
Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
[TBL] [Abstract][Full Text] [Related]
9. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Georgiannos SN; Renaut A; Goode AW; Sheaff M
Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
[TBL] [Abstract][Full Text] [Related]
10. Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumors of the pancreas.
Ryschich E; Autschbach F; Eisold S; Klar E; Buchler MW; Schmidt J
Tissue Antigens; 2003 Jul; 62(1):48-54. PubMed ID: 12859594
[TBL] [Abstract][Full Text] [Related]
11. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
[TBL] [Abstract][Full Text] [Related]
12. [Expression of HLA class II antigen-associated invariant chain on renal cell cancer].
Saito T; Tomita Y; Kimura M; Nishiyama T; Sato S
Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1036-40. PubMed ID: 8345720
[TBL] [Abstract][Full Text] [Related]
13. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
14. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients.
Whitford P; George WD; Campbell AM
Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer.
Hosch SB; Meyer AJ; Schneider C; Stoecklein N; Prenzel KL; Pantel K; Broelsch CE; Izbicki JR
J Gastrointest Surg; 1997; 1(4):316-23. PubMed ID: 9834364
[TBL] [Abstract][Full Text] [Related]
17. Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.
Nouri AM; Hussain RF; Oliver RT; Handy AM; Bartkova I; Bodmer JG
Eur J Cancer; 1993; 29A(13):1895-9. PubMed ID: 8260249
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T
Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651
[TBL] [Abstract][Full Text] [Related]
19. Association between HLA-expression and infiltration of immune cells in cervical carcinoma.
Hilders CG; Houbiers JG; van Ravenswaay Claasen HH; Veldhuizen RW; Fleuren GJ
Lab Invest; 1993 Dec; 69(6):651-9. PubMed ID: 8264228
[TBL] [Abstract][Full Text] [Related]
20. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
